[Reuters] – The European Commission has authorised two types of Monsanto’s genetically modified seeds and one sold by Germany’s Bayer for feed and food uses, following a favourable assessment by Europe’s scientific … Read more on this. , with a current market cap of $recting to http://finance.ya, finished yesterday at $. During the trading session, MON traded between $ with a one year range of $. Monsanto (MON) shares are currently priced at x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s x earnings multiple for the same period. According to a consensus of 0 analysts, the earnings estimate of $ per share would be $0.00 worse than the year-ago quarter and a $0.00 sequential decrease. Investors should also note that the full-year EPS estimate of $ is a $0.00 worse when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $0.00 . If reported, that would be a 0.00% decrease over the year-ago quarter. Recently, d MON from to (/fi). Previously, d MON from to . When considering if perhaps the stock is under or overvalued, the average price target is $, which is 0.00% below where the stock opened this morning. See more in (NYSE:MON) Similar Articles: Market Update (NYSE:MON): Monsanto rejects Bayer’s sweetened offer, open to talks Market Update: Monsanto Company (NYSE:MON) – Bayer expands financing group for Monsanto bid-source Market Update: Monsanto Company (NYSE:MON) – Bayer could get ECB financing for Monsanto bid, rules show